Bank of New York Mellon’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-155,302
Closed -$11.7M 4634
2022
Q2
$11.7M Sell
155,302
-52,804
-25% -$3.97M ﹤0.01% 1842
2022
Q1
$5.59M Sell
208,106
-884
-0.4% -$23.7K ﹤0.01% 2360
2021
Q4
$9.97M Sell
208,990
-9,492
-4% -$453K ﹤0.01% 2103
2021
Q3
$14.5M Buy
218,482
+18,782
+9% +$1.25M ﹤0.01% 1912
2021
Q2
$15.6M Buy
199,700
+42,742
+27% +$3.33M ﹤0.01% 1874
2021
Q1
$14.8M Sell
156,958
-13,149
-8% -$1.24M ﹤0.01% 1875
2020
Q4
$20.7M Buy
170,107
+17,071
+11% +$2.08M ﹤0.01% 1615
2020
Q3
$13.4M Buy
153,036
+31,551
+26% +$2.76M ﹤0.01% 1696
2020
Q2
$7.85M Buy
121,485
+17,109
+16% +$1.11M ﹤0.01% 1972
2020
Q1
$4.66M Buy
104,376
+1,694
+2% +$75.6K ﹤0.01% 2104
2019
Q4
$6.4M Buy
102,682
+55,833
+119% +$3.48M ﹤0.01% 2214
2019
Q3
$1.76M Buy
46,849
+16,090
+52% +$605K ﹤0.01% 2815
2019
Q2
$1.25M Buy
+30,759
New +$1.25M ﹤0.01% 3073